44 "

: Rebif 44 Mcg. ?  »
|
-

S.C

Solution For Injection

Rebif (interferone beta-1a) is indicated for the treatment of patients with relapsing forms of multiple sclerosis to decrease the frequency of clinical exacerbations and delay the accumulation of physical disability. Efficacy of Rebif in chronic progressive multiplbe sclerosis has not been established.Rebif is indicated for the treatment of patients with a single demyelinating event with an active inflammatory process, if alternative diagnoses have been excluded, and if they are determined to be at high risk of developing clinically definite multiple sclerosis.These patients should have MRI findings which are compatible with the diagnosis of multiple sclerosis.

116 35 29814 06

Merck Serono S.a., Switzerland

01/2013 - 01/2023

.
, .
.
/
Interferon beta 44 MCG / 0.5 ML
Cartridge glass type i 4 x 1.5 ML 18
Syringe prefilled glass type i 1 x 0.5 ML 18
Syringe prefilled glass type i 3 x 0.5 ML 18
Syringe prefilled glass type i 12 x 0.5 ML 18

*

*

 

.

 
" !
 
238
, ,